Do You Want to Get the Take on Points?

I think that this data is exciting to me and, and quite promising in terms of changing the standard of care for first and second line C diff infection. The issue that we had talked a little bit about before that I think remains to be worked out is standardization of these products and accessibility of these products. But we do now have an FDA approved fecal transplant drug as of December 2022 so I think this is going to start seeing this once the logistics are worked out  and maybe there'll be more trials but there I think we're going to start see it earlier people go to these earlier than they have seen in the past.